Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Health outcomes associated with methamphetamine use among young people: a systematic review.

Marshall BD, Werb D.

Addiction. 2010 Jun;105(6):991-1002. doi: 10.1111/j.1360-0443.2010.02932.x. Review.

PMID:
20659059
2.

Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.

Plüddemann A, Dada S, Parry CD, Kader R, Parker JS, Temmingh H, van Heerden S, de Clercq C, Lewis I.

Afr J Psychiatry (Johannesbg). 2013 Jan;16(1):45-9. doi: http://dx.doi.org/10.4314/ajpsy.v16i1.8.

3.

Psychotic symptoms in methamphetamine psychotic in-patients.

Srisurapanont M, Ali R, Marsden J, Sunga A, Wada K, Monteiro M.

Int J Neuropsychopharmacol. 2003 Dec;6(4):347-52.

PMID:
14604449
4.

Why do we need an Addiction supplement focused on methamphetamine?

Rawson RA, Condon TP.

Addiction. 2007 Apr;102 Suppl 1:1-4.

PMID:
17493048
5.

Personality traits and mental health states of methamphetamine-dependent and methamphetamine non-using MSM.

Solomon TM, Kiang MV, Halkitis PN, Moeller RW, Pappas MK.

Addict Behav. 2010 Feb;35(2):161-3. doi: 10.1016/j.addbeh.2009.09.002. Epub 2009 Sep 9.

6.

Clinical course and outcomes of methamphetamine-dependent adults with psychosis.

Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R; Methamphetamine Treatment Project Corporate Authors.

J Subst Abuse Treat. 2008 Dec;35(4):445-50. doi: 10.1016/j.jsat.2007.12.004. Epub 2008 Feb 21.

PMID:
18294802
7.

Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period.

Gonzales R, Ang A, Marinelli-Casey P, Glik DC, Iguchi MY, Rawson RA; Methamphetamine Treatment Project Corporate Authors.

J Subst Abuse Treat. 2009 Dec;37(4):353-61. doi: 10.1016/j.jsat.2009.04.001. Epub 2009 Jun 23.

PMID:
19553066
8.

Methamphetamine use among young adults: health and social consequences.

Sommers I, Baskin D, Baskin-Sommers A.

Addict Behav. 2006 Aug;31(8):1469-76. Epub 2005 Nov 23.

PMID:
16309848
9.

Clinical effects and management of methamphetamine abuse.

Romanelli F, Smith KM.

Pharmacotherapy. 2006 Aug;26(8):1148-56. Review.

PMID:
16863490
10.

Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.

Griffiths P, Mravcik V, Lopez D, Klempova D.

Drug Alcohol Rev. 2008 May;27(3):236-42. doi: 10.1080/09595230801932588. Review.

PMID:
18368604
11.

Hostility among methamphetamine users experiencing psychotic symptoms.

McKetin R, McLaren J, Lubman DI, Hides L.

Am J Addict. 2008 May-Jun;17(3):235-40. doi: 10.1080/10550490802019816.

PMID:
18464001
12.

Major physical and psychological harms of methamphetamine use.

Darke S, Kaye S, McKetin R, Duflou J.

Drug Alcohol Rev. 2008 May;27(3):253-62. doi: 10.1080/09595230801923702. Review.

PMID:
18368606
13.

The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.

Sulaiman AH, Said MA, Habil MH, Rashid R, Siddiq A, Guan NC, Midin M, Nik Jaafar NR, Sidi H, Das S.

Compr Psychiatry. 2014 Jan;55 Suppl 1:S89-94. doi: 10.1016/j.comppsych.2013.01.003. Epub 2013 Feb 19.

PMID:
23433219
14.

[Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].

Härtel-Petri R, Rodler R, Schmeisser U, Steinmann J, Wolfersdorf M.

Psychiatr Prax. 2005 Jan;32(1):13-7. German.

PMID:
15633070
15.

Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region.

Farrell M, Marsden J, Ali R, Ling W.

Addiction. 2002 Jul;97(7):771-2. No abstract available. Erratum in: Addiction 2002 Nov;97(11):1475.

PMID:
12133111
16.

Methamphetamine and its impact on dental care.

Klasser GD, Epstein J.

J Can Dent Assoc. 2005 Nov;71(10):759-62.

17.

The epidemiology of methamphetamine use and harm in Australia.

Degenhardt L, Roxburgh A, Black E, Bruno R, Campbell G, Kinner S, Fetherston J.

Drug Alcohol Rev. 2008 May;27(3):243-52. doi: 10.1080/09595230801950572. Review.

PMID:
18368605
18.

The methamphetamine epidemic and dentistry.

Klasser GD, Epstein JB.

Gen Dent. 2006 Nov-Dec;54(6):431-9; quiz 440, 448.

PMID:
17134084
19.

Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.

Degenhardt L, Baker A, Maher L.

Drug Alcohol Rev. 2008 May;27(3):217-9. doi: 10.1080/09595230801956538. No abstract available.

PMID:
18368601
20.

Will the methamphetamine problem go away?

Rawson RA, Anglin MD, Ling W.

J Addict Dis. 2002;21(1):5-19. Review.

PMID:
11831500
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk